About
Pyxis Oncology Inc (NASDAQ:PYXS) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 17 2026
Pyxis Oncology to Present New Preclinical Data Showing Synergistic Anti-Tumor Activity in a HNSCC model with maMICVO in Combination with Anti-PD-1 at AACR 2026
Mar 23 2026
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Feb 3 2026
Pyxis Oncology Announces Interim CEO Appointment and Leadership Transition to Support Strategic Focus and Program Continuity
Dec 18 2025
Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Nov 3 2025
Pyxis Oncology to Participate in Upcoming Investor Conferences